SCHEMBL512564

SCHEMBL512564

CC#CCCCCCCCCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 5/20 0.48
HMGCR P04035 3/20 0.48
TSHR P16473 1/20 0.47
THRB P10828 1/20 0.47
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
KCNH2 Q12809 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9015927 1.00 PTPN7 (0.48) PTPN7HMGCRTSHRTHRBRAB9A
SCHEMBL1760681 1.00 PTPN7 (0.48) PTPN7HMGCRTSHRTHRBRAB9A
SCHEMBL1602080 1.00 PTPN7 (0.48) PTPN7HMGCRTSHRTHRBRAB9A
SCHEMBL5166822 1.00 PTPN7 (0.48) PTPN7HMGCRTSHRTHRBRAB9A
SCHEMBL9015838 1.00 PTPN7 (0.48) PTPN7HMGCRTSHRTHRBRAB9A
SCHEMBL513133 1.00 PTPN7 (0.48) PTPN7HMGCRTSHRTHRBRAB9A
SCHEMBL514166 1.00 PTPN7 (0.48) PTPN7HMGCRTSHRTHRBRAB9A
SCHEMBL1174096 1.00 PTPN7 (0.48) PTPN7HMGCRTSHRTHRBRAB9A
SCHEMBL54883 1.00
SCHEMBL6561950 1.00 PTPN7 (0.48) PTPN7HMGCRTSHRTHRBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371995-B1 PROCESS FOR PRODUCING PHENYLHYDROQUINONES EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1993-01-20 EP claimed
CN-108558975-A 12 beta-hydroxies-androstane-14,14- diene -16- ketone compounds and its application 昆明理工大学 2018-09-21 CN disclosed
CN-108191937-A A kind of polyenoid androstane ketone compound and its application 昆明理工大学 2018-06-22 CN disclosed
CN-105311008-B The purposes of stearoyl amino acid or its pharmaceutical salts 上海交通大学医学院 2018-03-06 CN disclosed
CN-107249589-A Physiological activator combination block copolymer 日本化药株式会社 2017-10-13 CN disclosed
CN-106966960-A A kind of phenol nitrogen-containing compound and its application 昆明理工大学 2017-07-21 CN disclosed
CN-103582730-B Oil agent for carbon fiber precursor acrylic fiber, oil agent composition for carbon fiber precursor acrylic fiber, oil agent treatment liquid for carbon fiber precursor acrylic fiber, carbon fiber precursor acrylic fiber bundle, and method for producing carbon fiber bundle using same 三菱丽阳株式会社 2017-03-29 CN disclosed
US-8758777-B2 Pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles and uses thereof BAR-ILAN UNIVERSITY (IL) 2014-06-24 US disclosed
US-20120027809-A1 Pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles and uses thereof BAR-LLAN UNIVERSITY (IL) 2012-02-02 US disclosed
CN-100363390-C Process for the preparation of hydroxy-vinyl-aromatic polymers or copolymers by anionic or controlled radical polymerization CIBA SC HOLDING AG (CH) 2008-01-23 CN disclosed
CN-1599777-A Organic solvent-free process for the preparation of 2-(2-nitrophenylazo)phenols CIBA SC HOLDING AG (CH) 2005-03-23 CN disclosed
EP-1471054-A1 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE Sankyo Company, Limited (JP) 2004-10-27 EP disclosed
US-20040132784-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2004-07-08 US disclosed
US-6723745-B2 PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL SANKYO COMPANY, LIMITED (JP) 2004-04-20 US disclosed
US-20030236297-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2003-12-25 US disclosed
CN-1128799-C Photoactivatable nitrogen-containing bases based on alpha-amino olefins CIBA SC HOLDING AG (CH) 2003-11-26 CN disclosed
EP-1300405-A1 AMINO ALCOHOL DERIVATIVES Sankyo Company, Limited (JP) 2003-04-09 EP disclosed
CN-1251103-A Photoactivatable nitrogen-containing bases based on alpha-amino olefins CIBA SC HOLDING AG (CH) 2000-04-19 CN disclosed
EP-0748823-A1 Catalyst composition and process for the production of olefinic polymers NIPPON OIL CO. LTD. (JP) 1996-12-18 EP disclosed
US-3969196-A Process for the separation of mixtures of substances STUDIENGESELLSCHAFT KOHLE M.B.H. (DT) 1976-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236297-A1 Amino alcohol derivatives CD4, ADH1C, ADH1A PTPN7 2680/4885HMGCR 789/4885TSHR 1187/4885
US-20040132784-A1 Amino alcohol derivatives CD4, ADH1C, ADH1A PTPN7 2680/4885HMGCR 789/4885TSHR 1187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.